United Services Automobile Association Blueprint Medicines Corp Transaction History

United Services Automobile Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$72.9 - $101.41 $566,433 - $787,955	-7,770 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$73.54 - $97.8 $88,836 - $118,142	1,208 Added 18.41%	7,770 $733,000
Q3 2018 Nov 13, 2018	BUY	$58.91 - $78.32 $1,354 - $1,801	23 Added 0.35%	6,562 $512,000
Q2 2018 Aug 10, 2018	BUY	$60.96 - $101.18 $15,179 - $25,193	249 Added 3.96%	6,539 $415,000
Q1 2018 May 14, 2018	BUY	$73.28 - $102.95 $460,931 - $647,555	6,290 New	6,290 $577,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.